Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Equity Ratio (2018 - 2023)

Avai Bio's Equity Ratio history spans 5 years, with the latest figure at 4.81 for Q4 2023.

  • For Q4 2023, Equity Ratio fell 154.01% year-over-year to 4.81; the TTM value through Dec 2023 reached 4.81, down 154.01%, while the annual FY2023 figure was 2.62, N/A changed from the prior year.
  • Equity Ratio for Q4 2023 was 4.81 at Avai Bio, down from 3.74 in the prior quarter.
  • Across five years, Equity Ratio topped out at 1.0 in Q1 2019 and bottomed at 7.2 in Q2 2019.
  • The 4-year median for Equity Ratio is 1.19 (2022), against an average of 1.77.
  • The largest YoY upside for Equity Ratio was 3736.08% in 2019 against a maximum downside of 394.62% in 2019.
  • A 4-year view of Equity Ratio shows it stood at 1.0 in 2019, then plummeted by 152.68% to 0.53 in 2020, then crashed by 259.45% to 1.89 in 2022, then plummeted by 154.01% to 4.81 in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Equity Ratio are 4.81 (Q4 2023), 3.74 (Q3 2023), and 3.62 (Q2 2023).